Correlation Between Basilea Pharmaceutica and Relief Therapeutics

Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Basilea Pharmaceutica AG and Relief Therapeutics Holding, you can compare the effects of market volatilities on Basilea Pharmaceutica and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Relief Therapeutics.

Diversification Opportunities for Basilea Pharmaceutica and Relief Therapeutics

-0.72

Correlation Coefficient

Basilea Pharmaceutica  Relief Therapeutics

Pay attention - limited upside

The 3 months correlation between Basilea and Relief is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Relief Therapeutics go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Relief Therapeutics

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.4 times more return on investment than Relief Therapeutics. However, Basilea Pharmaceutica AG is 2.52 times less risky than Relief Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about -0.19 per unit of risk. If you would invest  4,115  in Basilea Pharmaceutica AG on December 22, 2024 and sell it today you would earn a total of  620.00  from holding Basilea Pharmaceutica AG or generate 15.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Basilea Pharmaceutica AG  vs.  Relief Therapeutics Holding

Basilea Pharmaceutica

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Basilea Pharmaceutica AG are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Basilea Pharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Relief Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Relief Therapeutics Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Basilea Pharmaceutica and Relief Therapeutics

The main advantage of trading using opposite Basilea Pharmaceutica and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.

The idea behind Basilea Pharmaceutica AG and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.